Evolve’s Christopher Busuttil Delbridge appointed Mentor at TechForCann Europe

Christopher Busuttil Delbridge, Chief Visionary Officer at local science company Evolve, has joined TechForCann Europe – the continent’s first-ever medical cannabis business innovation project – as a Mentor.

In this role, Mr Busuttil Delbridge will be tasked with supporting the next generation of entrepreneurs in the growing medical cannabis industry.

“I am thrilled to be involved with TechForCann Europe and can’t wait to get started,” the Chief Visionary Officer said.

“I am looking forward to meeting the next generation of entrepreneurs with the ideas and potential to significantly grow our industry and give even more patients around the world access to the benefits of medical cannabis,” he continued.

Malta’s government invested €2.5 million in TechForCann Europe, which will be headquartered on the island. The business accelerator scheme is expected to support 20 new start-ups over the next 18 months.

“I believe innovation is the key to accelerating growth, and my aim is to provide guidance, contacts, and identify resources to further develop a range of new processes that are clinically validated, safe, sustainable, and cost-effective,” Mr Busuttil Delbridge added.

Mr Busuttil Delbridge built Evolve within the Attard & Co Group from scratch. He recently internationalised the brand, becoming the first company in the world to design and build an EU-standard GMP laboratory in West Africa.

The Chief Visionary Officer also chairs two units within The Malta Chamber; the Medical Cannabis Operators Business Section and the Quality Committee.